Encana Corp (ECA) Stake Boosted by Eqis Capital Management Inc
Now the shares of Encana Corporation (ECA) has a trading volume of 10.61 Million shares, with an average trading volume of 9820 shares – with shares dropping to a 52 week low of $7.04, and the company’s shares hitting a 52 week high of $ 13.83. It has by 0.00% the S&P500. Cambridge Investment Research Advisors Inc. boosted its position in shares of Encana Corp by 0.6% in the first quarter. The company reported revenue of $850.87 Million in the same period a year ago. Ch Robinson Worldwide Inc now has $9.35 billion valuation.
According to Finviz reported data, The SMA20 of the stock is at 1.87 percent, SMA50 is 0.6 percent, while SMA200 is 0.51 percent. About 3.97M shares traded. Encana Corporation (ECA) 52 week low value is at $6.88 and its current distance from 52 week low value is 62.09%.
Before looking at the financial values or the trading statistics of Encana Corporation (ECA), we will start our analysis with the SMA or Simple Moving Average values. They expect $0.05 earnings per share, down 50.00% or $0.05 from last year’s $0.1 per share.
All things being equal, stocks with higher earnings-per-share growth rates are generally more desirable than those with slower earnings-per-share growth rates. One research analyst has rated the stock with a sell rating, four have issued a hold rating and one has issued a buy rating to the company. Therefore 65% are positive.
ECA has a 1-year high price of $ 13.83 and 1-year low price of $7.04.
The stock of Encana Corp (USA) (ECA) formed H&S with $10.54 target or 5.00 % below today’s $11.09 share price. Barclays Capital maintained it with “Equal-Weight” rating and $6 target in Wednesday, January 6 report. RBC Capital Markets upgraded Encana Corp (USA) (NYSE:ECA) rating on Friday, November 4. The company’s market cap is $11.1 Billion, and the average volume is 11.48 Million. Finally, AltaCorp Capital restated a “sector perform” rating on shares of Encana Corp in a research note on Tuesday, May 2nd. The firm has “Hold” rating by TD Securities given on Friday, January 27. The stock of Encana Corp (USA) (NYSE:ECA) has “Buy” rating given on Monday, October 10 by. The rating was reinitiated by Jefferies on Tuesday, December 1 with “Hold”. The company was maintained on Saturday, September 5 by BMO Capital Markets. The legal version of this piece can be read at https://www.chaffeybreeze.com/2017/05/19/douglas-james-suttles-buys-1000-shares-of-encana-corp-eca-stock-updated.html. The institutional investor owned 37,687 shares of the oil and gas company’s stock after buying an additional 11,642 shares during the period. The firm has “Market Outperform” rating given on Tuesday, March 15 by JMP Securities. Zacks downgraded the shares of CHRW in report on Friday, August 28 to “Buy” rating. The firm earned “Neutral” rating on Thursday, October 6 by Macquarie Research. The firm has “Outperform” rating given on Wednesday, September 2 by Wolfe Research. JP Morgan initiated the shares of ECA in report on Wednesday, February 15 with “Overweight” rating.
Redmile Group Llc decreased Gw Pharmaceuticals Plc (NASDAQ:GWPH) stake by 179,854 shares to 366,068 valued at $40.91 million in 2016Q4. Boston Scientific Corp (NYSE:BSX) was reduced too. About 900 shares traded. The stock, after opening at $11.4, hit $11.15 through the close by scoring -1.5%.
A number of large investors have recently modified their holdings of the company. FMR LLC now owns 22,080,449 shares of the oil and gas company’s stock worth $258,686,000 after buying an additional 1,309,218 shares during the last quarter. Prudential Fincl Inc holds 0.02% or 199,619 shares.
Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.